Tylenol is owned by Kenvue (the United States, NYSE: KVUE), which was separated from Johnson & Johnson on 23 August 2023.[1][2] Before Kenvue, Tylenol was owned by Johnson & Johnson from 1959 to 2023.[2]
Tylenol is an acetaminophen pain reliever launched in 1955 and sold as an aspirin alternative for people who could not tolerate it. Seven deaths from cyanide-laced capsules in Chicago in 1982 led to the recall of 31 million bottles and produced the tamper-evident packaging now standard across the industry.
What Kenvue's annual report says about Tylenol
Sentences about Tylenol from Kenvue's latest annual filing[1], copied word for word.
In addition, our affiliate Johnson & Johnson Consumer Inc., now known as Kenvue Brands LLC ("New JJCI"), has been named in cases, including one brought in October 2025 by the Attorney General of the State of Texas, alleging that exposure to Tylenol , an acetaminophen product, is associated with the development of autism spectrum disorder and attention-deficit/hyperactivity disorder in children.
How often Kenvue names Tylenol in its annual report
A plain count of the times the name appears in the text of each annual report, not counting the start of a sentence. A brand that an owner writes about more is usually one it treats as central.
Kenvue is a publicly listed company headquartered in Summit, New Jersey, United States, founded in 2023. Brandtree records 13 brands under its control, and it is listed as NYSE: KVUE.
Kenvue is the consumer health business separated from Johnson & Johnson, listed in May 2023 and fully split off that August. It holds the self-care, skin health and essential health brands that Johnson & Johnson had built up over a century. Kimberly-Clark agreed to acquire Kenvue in November 2025.
Brandtree records a controlling owner for 2,549 brands that began in the United States.
478 of them (19%) are now controlled by a company headquartered in another country; Tylenol is not one of them.
Kimberly-Clark agreed to acquire Kenvue for $3.50 in cash plus 0.14625 Kimberly-Clark shares for each Kenvue share, which would combine Huggies and Kleenex with Tylenol, Listerine and Neutrogena. Kimberly-Clark expects to issue about 280 million shares and pay about $6.7 billion in cash, leaving its existing shareholders with about 54 per cent of the combined company.
Johnson & Johnson separated its consumer health business as Kenvue, which listed in May 2023 and was fully split off through an exchange offer completed on 23 August 2023. Tylenol, Band-Aid, Listerine, Neutrogena and Johnson's Baby all moved to the new company.
1 recall notice from government regulators matched to Tylenol.
Each applies to the specific products, sizes and lot codes named in the notice, not to every product sold under the name.
Matched automatically from FDA, USDA FSIS, UK Food Standards Agency and CPSC records only when the recalling firm corresponds to this ownership record and, for a brand, the brand name appears in the product description. Check the linked notice for exact products and lots. Method.
Frequently asked questions
Who is the parent company of Tylenol?
⌄
The parent company of Tylenol is Kenvue, a publicly listed company headquartered in the United States.
Is Tylenol American?
⌄
Yes. Tylenol originated in the United States in 1955 and its owner, Kenvue, is also headquartered in the United States.
Since when has Kenvue owned Tylenol?
⌄
Kenvue has owned Tylenol since 23 August 2023.
Who owned Tylenol before Kenvue?
⌄
Before Kenvue, Tylenol was owned by Johnson & Johnson from 1959 until 2023.
Is Tylenol still owned by Kenvue?
⌄
Yes. As of 9 October 2026, Tylenol is still owned by Kenvue. The ownership record was last checked against primary sources on that date.
Sources (3) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
Brandtree needs to remember this choice and does not set any other cookie unless you accept.
If you choose “Accept all”, we also use Google Analytics cookies to count visits and see which pages help, so we can improve the site.
If you choose “Accept required”, no analytics cookie is set. Google Analytics still receives a cookieless ping with the page address and your IP address. No advertising is used either way. Privacy policy